BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6300693)

  • 1. Rapid development of tolerance to the behavioural actions of cholecystokinin.
    Crawley JN; Beinfeld MC
    Nature; 1983 Apr; 302(5910):703-6. PubMed ID: 6300693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic intraventricular administration of cholecystokinin octapeptide (CCK-8) suppresses feeding in rats.
    Schick RR; Stevens CW; Yaksh TL; Go VL
    Brain Res; 1988 May; 448(2):294-8. PubMed ID: 3378151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eating, drinking and temperature responses to intracerebroventricular cholecystokinin in the chick.
    Denbow DM; Myers RD
    Peptides; 1982; 3(5):739-43. PubMed ID: 6294630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complex.
    Cooper MS; Reeve JR; Abdalla MO; Moyer L; Raboin SJ; Green GM; Sayegh AI
    Brain Res; 2008 Apr; 1205():27-35. PubMed ID: 18346716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of tolerance development with long-term administration of PEGylated cholecystokinin.
    Verbaeys I; León-Tamariz F; Buyse J; Decuypere E; Pottel H; Cokelaere M
    Peptides; 2009 Apr; 30(4):699-704. PubMed ID: 19084041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCK-58 prolongs the intermeal interval, whereas CCK-8 reduces this interval: not all forms of cholecystokinin have equal bioactivity.
    Sayegh AI; Washington MC; Raboin SJ; Aglan AH; Reeve JR
    Peptides; 2014 May; 55():120-5. PubMed ID: 24607725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholecystokinin and caerulein on human eating behavior and pain sensation: a review.
    Stacher G
    Psychoneuroendocrinology; 1986; 11(1):39-48. PubMed ID: 3085129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amylin on feeding of goldfish: interactions with CCK.
    Thavanathan R; Volkoff H
    Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of peripheral cholecystokinin-satiety in the capsaicin treated rat.
    MacLean DB
    Regul Pept; 1985 Aug; 11(4):321-33. PubMed ID: 2413505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion of cholecystokinin between meals into free-feeding rats fails to prolong the intermeal interval.
    West DB; Greenwood MR; Sullivan AC; Prescod L; Marzullo LR; Triscari J
    Physiol Behav; 1987; 39(1):111-5. PubMed ID: 3562644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amylase secretion by isolated pancreatic acini after chronic cholecystokinin treatment in vivo.
    Otsuki M; Williams JA
    Am J Physiol; 1983 Jun; 244(6):G683-8. PubMed ID: 6190411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The satiety effect of cholecystokinin: a progress report.
    Smith GP; Gibbs J; Jerome C; Pi-Sunyer FX; Kissileff HR; Thornton J
    Peptides; 1981; 2 Suppl 2():57-9. PubMed ID: 6283497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin octapeptide and gastric mechanoreceptor activity in rat brain.
    Ewart WR; Wingate DL
    Am J Physiol; 1983 Jun; 244(6):G613-7. PubMed ID: 6305211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCK-octapeptide injected in CSF decreases meal size and daily food intake in sheep.
    Della-Fera MA; Baile CA
    Peptides; 1980; 1(1):51-4. PubMed ID: 6264407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?
    Trevaskis JL; Turek VF; Griffin PS; Wittmer C; Parkes DG; Roth JD
    Physiol Behav; 2010 May; 100(2):187-95. PubMed ID: 20206194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
    Crawley JN; St-Pierre S; Gaudreau P
    J Pharmacol Exp Ther; 1984 Aug; 230(2):438-44. PubMed ID: 6086888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-33 acutely attenuates food foraging, hoarding and intake in Siberian hamsters.
    Teubner BJ; Bartness TJ
    Peptides; 2010 Apr; 31(4):618-24. PubMed ID: 20025915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of [3H]-dopamine binding by cholecystokinin octapeptide (CCK-8).
    Murphy RB; Schuster DI
    Peptides; 1982; 3(3):539-43. PubMed ID: 6289286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous glucagon-like peptide-1 reduces body weight and cholecystokinin-8 enhances this reduction in diet-induced obese male rats.
    Mhalhal TR; Washington MC; Newman K; Heath JC; Sayegh AI
    Physiol Behav; 2017 Oct; 179():191-199. PubMed ID: 28647503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.